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Objectives This report sought to study the impact of the balloon-expandable SAPIEN XT (Edwards
Lifesciences, Irvine, California) transcatheter heart valve (THV) stent frame geometry and position on
outcomes of transcatheter aortic valve replacement (TAVR).
Background Post-implant THV geometry and position might impact atrioventricular conduction,
hemodynamic performance, and annular sealing.
Methods Eighty-nine consecutive patients who underwent TAVR with a Sapien XT THV had pre-
and post-implant multidetector computed tomography, transthoracic echocardiography, and electro-
cardiograms performed to assess THV stent geometry, atrioventricular conduction, and hemody-
namic performance.
Results The THV Circularity (THV eccentricity 10% [eccentricity  minimum stent diameter/maxi-
mum stent diameter]) and under-expansion (THV area/nominal THV area 90%) were present in
97.8% (2 of 89) and 0%, respectively. Low THV implantation was associated with new left bundle
branch block and complete heart block (3.4  2.0 mm vs. 5.5  2.9 mm, p  0.01) and with the
need for permanent pacemaker implantation (3.5  2.0 mm vs. 7.1  2.5 mm, p  0.001). In con-
trast, labeled THV size and THV area oversizing was not associated with atrioventricular conduction
disturbances. The relation between inﬂow stent frame area and annular area was related to paraval-
vular regurgitation (p  0.025). Labeled prosthesis size but not prosthesis expansion or eccentricity
was related to valve gradient (p  0.005) and effective oriﬁce area (p  0.001).
Conclusions Low implantation depth of balloon-expandable THVs is associated with clinically
signiﬁcant new conduction disturbances and permanent pacemaker implantation. Importantly,
annular area oversizing was not associated with these complications. (J Am Coll Cardiol Intv
2013;6:462–8) © 2013 by the American College of Cardiology Foundation
From the St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Drs. Binder, Webb, Wood,
and Leipsic are consultants to Edwards Lifesciences. Dr. Leipsic has served on the speakers’ bureau for Edwards Lifesciences. Drs.
Binder and Toggweiler have received unrestricted research grants from the Swiss National Foundation. All other authors have
reported that they have no relationships relevant to the contents of this paper to disclose.Manuscript received October 5, 2012; revised manuscript received November 30, 2012, accepted December 21, 2012.
m
a
a
(
U
a
e
d
(
w
b
6
H
p
c
3
g
C
m
s
r
0
R
d
c
c
w
d
d
b
M
h
a
o
e
m
o
t
a
T
b
m
T
w
c
e
e
s
c
e
3
o
fi
o
t
U
a
a
p
n
t
d
s
t
d
d
a
w
t
c
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 5 , 2 0 1 3 Binder et al.
MA Y 2 0 1 3 : 4 6 2 – 8 Impact of Post-implant SAPIEN XT Geometry
463Balloon-expandable transcatheter heart valves (THV) are
compressible bioprostheses that are crimped for introduc-
tion to obtain functional shape after deployment (1,2).
Optimal performance and durability assume complete and
symmetrical expansion (3) in the correct position. Implant
height (4–6) and incomplete or asymmetrical expansion (7)
ight affect leaflet coaptation, effective orifice area, valvular
nd paravalvular regurgitation (PAR), stent anchoring,
trioventricular conduction, or THV durability. There is,
See page 469
however, a paucity of data and limited assessment of the impact
of post-implant balloon-expandable THV geometry on cardiac
conduction disturbances, PAR, and hemodynamic perfor-
mance. Our group has previously shown that patients requiring
a permanent pacemaker (PPM) had low implanted balloon-
expandable THVs, but the study size was too small for
statistical analysis (4). Post-implant balloon-expandable THV
eccentricity has also been shown to impact PAR in another
study (7), but again the cohort was small with only 42 patients.
Therefore, we sought to evaluate the post-implant THV
geometry and position of the SAPIEN XT (Edwards Life-
sciences, Irvine, California) THV by multidetector computed
tomography (MDCT) and its impact on atrioventricular con-
duction, hemodynamic performance, and PAR in a large
cohort of consecutive patients undergoing transcatheter aortic
valve replacement (TAVR).
Methods
Subjects. Patients with symptomatic severe aortic stenosis
all tricuspid), who underwent TAVR at St. Paul’s Hospital,
niversity of British Columbia, Vancouver, Canada, were
ssessed by pre- and post-implant MDCT, transthoracic
chocardiography (TTE), and 12-lead standard electrocar-
iograms (ECG). A transesophageal echocardiogram
TEE) was performed during TAVR. All patients gave
ritten informed consent, and the procedure was approved
y the local ethics committee.
MDCT. The MDCT examinations were performed on a
4-slice high-definition scanner, Discovery HD 750 (GE
ealthcare, Waukesha, Wisconsin). A contrast-enhanced
rotocol with 80 to 120 ml of iodixanol 320 (GE Health-
are, Piscataway, New Jersey) injected at 5 ml/s followed by
0 ml of normal saline was used. Patients with an estimated
lomerular filtration rate 30 ml/m2 were not scanned.
ollimation width was 0.625 mm, detector coverage was 40
m, reconstructed slice thickness was 1.25 mm, and the
lice interval was 1.25 mm. Scan pitch was adjusted/heart
ate between 0.16 and 0.20, and gantry rotation time was
.35 s. Measurements were taken in diastole at 75% of the
-R interval, owing to optimal image quality and a lack of
ifference in stent size and configuration throughout theardiac cycle due to the rigid stent structure. Peak tube
urrent (300 to 725 mA) and tube voltage (100 to 120 kVp)
ere based on body mass index (body weight in kilograms
ivided by the squared height in meters), and ECG-gated
ose modulation was applied. To avoid the blooming and
eam hardening effect of the cobalt-chromium stent frame,
DCT images were reconstructed with both standard and
ard convolution kernels. The stent frame of each THV was
ssessed at 3 cross-sectional levels (inflow, mid-portion, and
utflow). The minimum external stent diameter, maximum
xternal stent diameter, and the external stent area were
easured at each level by tracing along the external margins
f the stent frame. An experienced level-3 cardiac computed
omography (CT) reader measured all stent levels 3 times,
nd the data represent the mean of the 3 measurements.
he CT angiography reader was
linded toward all outcome
easures of this study, including
TE, TEE, and ECG results as
ell as clinical outcome data.
The THV eccentricity was
alculated as: (1  [minimum
xternal stent diameter/maximum
xternal stent diameter]) as mea-
ured by MDCT. A THV was
onsidered noncircular, when the
ccentricity was 10% or more for all
levels (inflow, mid-portion, and
utflow).
The THV expansion was de-
ned as the MDCT-derived
uter stent frame area divided by
he nominal external valve area.
nder-expansion was defined as
n expansion ratio of 90% or less
t all 3 levels (inflow, mid-
ortion, and outflow).
Oversizing was defined as the
umerical difference between
he stent frame inflow short-axis diameter and the annulus
iameter measured by TTE (effective TTE diameter over-
izing) or TEE (effective TEE diameter oversizing). Effec-
ive MDCT area oversizing was defined as the MDCT-
erived outer stent frame area divided by the MDCT-
erived native annular area.
The distance from the stent frame inflow to the aortic
nnulus (most basal insertion of the native aortic leaflets)
as measured (THV implant height), and the distance from
he stent frame outflow to the inferior border of the left
oronary artery ostium was measured.
Echocardiography. Echocardiography was performed by 3
different operators, experienced in pre- and post-TAVR
echocardiography assessments, and was reported according
Abbreviations
and Acronyms
CHB  complete heart block
CT  computed tomography
ECG  electrocardiogram
LBBB  left bundle branch
block
MDCT  multidetector
computed tomography
PAR  paravalvular
regurgitation
PPM  permanent
pacemaker
RBBB  right bundle branch
block
TAVR  transcatheter aortic
valve replacement
TEE  transesophageal
echocardiography
THV  transcatheter heart
valve
TTE  transthoracic
echocardiographyto Valve Academic Research Consortium criteria (8). The
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464diameter of the aortic annulus was measured in 1 plane by
TTE in the parasternal long-axis view and by TEE in a
3-chamber view.
ECGs. All ECGs were read by a single cardiologist. A left
undle branch block (LBBB) was defined by a QRS width
120 ms, a broad, monophasic R-wave in I, V5, V6, the
absence of septal Q waves in leads I, V5, V6, delayed
intrinsicoid deflection (0.06 s) in left precordial leads, and
wide S-wave after initially small R waves in the right
precordial leads. A right bundle branch block (RBBB) was
defined by a QRS width 120 ms, a secondary R-wave in
the right precordial leads (rsr, rsR, or rSR), an S-wave in
left-sided leads (I, V5, V6), and delayed intrinsicoid deflec-
ion (0.05 s) in the right precordial leads.
Statistical analysis. Analyses were performed with the SPSS
statistics software (version 20.0, SPSS, Inc., Chicago, Illi-
nois). Continuous variables are reported as mean  SD.
Continuous variables were tested for a normal distribution
and compared by the Student t test. For comparison of more
than 2 continuous parametric variables, an analysis of
variance was used. Categorical variables were compared by
the Fisher exact test. All tests were 2-tailed, and a p value
below 0.05 was considered statistically significant.
Results
Patients. Eighty-nine consecutive patients who underwent
TAVR and post-TAVR MDCT at our institution were
included in this study. Baseline patient characteristics are
outlined in Table 1.
THV geometry. Diameters and areas of the THV stent at
he inflow, mid-portion, and outflow are shown in Table 2.
he THV expansions and circularities are shown in Table 3
ccording to THV sizes. No valves were under-expanded at
ll 3 levels (inflow, mid-portion, and outflow). Two valves
2.2%) were under-expanded at the mid-level, and 1 (1.1%)
as under-expanded at the outflow. Under-expansion and
he grade of expansion were not related to native MDCT
nnular measurements (short annular diameter, long annu-
ar diameter, annular area, annular eccentricity) or MDCT
rea oversizing of the native annulus.
All but 2 valves (2.2%) were circular. Circularity was not
elated to native MDCT annular eccentricity, diameter, or
rea. The THV stent outflow was on average 0.3  2.6 mm
elow the inferior border of the left coronary artery ostium, and
he THV stent inflow was on average 3.6  2.2 mm below the
ortic annulus (most basal insertion of the native aortic leaflets).
Atrioventricular conduction. Patients who had a pre-
existing PPM before TAVR (n 11; 12.4%) were excluded
from all conduction delay analysis. Four patients (5.1%)
required a new PPM, because of complete heart block
(CHB), and 4 patients (5.1%) developed a new LBBB.
Patients, who received a new PPM had a longer baseline
QRS width (108  22 ms vs. 138  25 ms, p  0.01), alonger baseline PR interval (188  37 ms vs. 290  0 ms,
p  0.009), and significantly lower implanted THVs
(inflow to annulus distance 3.5 2.0 mm vs. 7.1 2.5 mm,
p  0.001) (Fig. 1). There was a nonsignificant trend
toward more new PPM in patients with a pre-existing
RBBB (p 0.063). Age, baseline heart rate, THV size, and
HV annular area oversizing were not associated with the
eed for a new PPM (p  ns for all).
Patients who developed a new LBBB or CHB had a
onger baseline QRS width (107  21 ms vs. 128  31 ms,
p  0.01) and significantly lower implanted THVs (3.4 
2.0 mm vs. 5.5  2.9 mm, p  0.01).
The THV geometry and positions for each patient with a
new LBBB or CHB are shown in Table 4.
Hemodynamic performance. The mean gradient was re-
duced from 40.7  17.5 mm Hg to 10.7  4.2 mm Hg
post-TAVR (p  0.001), and the effective valve orifice area
increased from 0.69  0.16 cm2 to 1.66  0.42 cm2
Table 1. Patient Characteristics (n  89)
Age (yrs) 82 8
Sex 54 (61%) male, 35 (39%) female
Height (cm) 169 11
Weight (kg) 77 18
BMI (kg/m2) 27 6
Diabetes 28% (25)
Hypertension 84% (75)
Dyslipidemia 73% (65)
Smoking history 40% (36)
COPD 23% (20)
NYHA functional class
I 2% (2)
II 14% (12)
III 73% (65)
IV 11% (10)
Prior cerebrovascular accident 12% (11)
Prior open heart surgery 38% (34)
Porcelain aorta 12% (11)
Prior permanent pacemaker 12% (11)
Baseline LBBB 10.1% (9)
Baseline RBBB 10.1% (9)
Atrial ﬁbrillation 27% (24)
STS PROM (%) 7.1 4.3
GFR (ml/min) 59 20
Labeled prosthesis size (SAPIEN XT)
20 mm 2.2% (2)
23 mm 37.1% (33)
26 mm 52.8% (47)
29 mm 7.9% (7)
Values are mean SD, n (%), or % (n). SAPIEN XT (Edwards Lifesciences, Irvine, California).
BMI  body mass index; COPD  chronic obstructive pulmonary disease; GFR  glomerular
filtration rate; LBBB left bundle branch block; NYHA New York Heart Association functional
class; RBBB right bundle branch block; STS PROM Society of Thoracic Surgeons predicted risk
of mortality.post-TAVR (p  0.001). The THV geometry and effective
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465valve orifice areas were adjusted for labeled prosthesis size.
Stent diameter, area, expansion, and eccentricity were not
related to valve gradient or effective valve orifice area. The
only significant factor explaining the effective valve orifice
area or the valve gradient was the labeled prosthesis size
(Table 5).
PAR. Paravalvular regurgitation was absent in 22 (24.7%),
ild in 60 (67.4%), moderate in 5 (5.6%), and moderate-
o-severe in 2 (2.2%) patients. Due to the low rate of
ore-than-mild PAR, grades of PAR were bundled to the
inary outcome of mild-or-more and no PAR to assess
HV geometry predictors for PAR. Table 6 shows differ-
ences of various oversizing measurements between patients
with any versus no PAR. The stent inflow area in relation to
the native MDCT annular area (effective MDCT area
oversizing; p  0.025) and the difference between the
CT-measured stent inflow long-axis and the native annular
long-axis diameter (effective long-axis oversizing; p 
0.026) were associated with PAR, whereas actually the
THV stent diameter was undersized in comparison with the
MDCT native annulus long axis. There was a nonsignifi-
cant trend toward more PAR, when the difference of the
native annulus diameter measured by TEE to the THV
inflow diameter (effective TEE diameter oversizing) was
small (2.3  1.0 mm vs. 1.7  1.4 mm; p  0.067).
rosthesis size, THV expansion, THV eccentricity, or
HV inflow to annulus distance did not show any signifi-
ant association with PAR.
iscussion
Our study evaluating a large consecutive TAVR cohort
suggests that THV implantation depth, as defined by
MDCT, is strongly associated with clinically significant
Table 2. SAPIEN XT Post-Implant Stent Diameters and Areas
Labeled
Prosthesis Size
Inflow Mean
Diameter (mm)
Mid-Portion Mean
Diameter (mm)
Outflow Mean
Diameter (mm
20 mm 19.5 0.6 19.2 0.4 19.6 0.1
23 mm 23.1 0.7 23.0 0.8 23.0 0.8
26 mm 25.9 0.7 25.9 0.7 25.9 0.6
29 mm 28.8 0.3 28.7 0.3 28.6 0.4
There were no significant differences in valve areas or mean diameters at the inflow, mid-portion, a
Table 3. SAPIEN XT Post-Implant Valve Expansion and Eccentricity
Labeled
Prosthesis Size Inflow Expansion
Mid-Portion
Expansion
Outflow
Expansion
20 mm 104.6 1.6 105.1 6.8 103.5 10.8
23 mm 103.9 7.6 103.8 7.5 103.7 7.0
26 mm 101.9 5.4 102.1 5.4 102.9 5.1
29 mm 99.1 2.0 97.8 2.0 97.9 3.7Values are percentages. There were no significant differences in eccentricity or expansion between labeledconduction disturbances. Implantation depth was the only
post-THV measure that was associated with conduction
disturbances with annular area oversizing not showing a
convincing relationship with this outcome. The ability to
better understand potential causes of conduction abnormal-
ities is of significant importance, because it has been
previously shown that new onset LBBB (9) and other
conduction disturbances (10,11) post-TAVR predict worse
clinical outcomes (9). As such, our data help elucidate the
mechanisms of conduction disturbances post-TAVR and
possible strategies to reduce these complications in the
future.
The rates for new PPM implantations after TAVR vary
by the valve implanted (12). Although PPM rates after
implantation with a Medtronic CoreValve were 24.4%, the
rates with the SAPIEN and SAPIEN XT THV were
7.4% in the large UK Transcatheter Aortic Valve Im-
plantation registry (12). Previously identified risk factors
for a new PPM after TAVR include pre-existing RBBB
(5), low baseline heart rate (13), and age (13). For the
CoreValve prosthesis, oversizing (13) and the stent ex-
tending deeper into the left ventricular outflow tract (5)
have been proposed as reasons for more PPM implanta-
tions. Although THV size and oversizing the annulus are
commonly perceived as predictors for conduction distur-
bances, oversizing the native aortic annulus measured by
TTE, TEE, or MDCT or labeled valve size were not
associated with the need for a new PPM or the develop-
ment of conduction delays in our study. Importantly, our
data suggest that implantation depth defined as the
distance between the native annulus and the THV inflow
on MDCT is strongly associated with the need for a new
PPM and the occurrence of a new LBBB or CHB.
p Value
Inflow Area
(cm2)
Mid-Portion Area
(cm2)
Outflow Area
(cm2) p Value
0.759 3.3 0.1 3.3 0.2 3.3 0.3 0.941
0.878 4.3 0.3 4.3 0.3 4.3 0.3 0.944
0.950 5.4 0.3 5.4 0.2 5.5 0.3 0.156
0.762 6.6 0.1 6.5 0.3 6.5 0.2 0.290
ow within labeled valve sizes.
Value
Inflow
Eccentricity
Mid-Portion
Eccentricity
Outflow
Eccentricity p Value
0.941 3.2 2.4 0.5 0.7 2.5 0.7 0.374
0.944 2.5 2.6 2.5 3.1 2.7 2.6 0.876
0.156 2.4 2.2 2.8 2.5 2.4 2.9 0.488
0.290 3.5 1.9 2.9 1.9 4.3 2.6 0.215)pvalve sizes and between inflow, mid-portion, and outflow within single valve sizes.
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466Our data have potential practical implications for sizing
and positioning during TAVR. Although operators have
historically performed TAVR with a belief that stretching
the annulus causes atrioventricular block, our analysis sug-
gests that the pressure of the stent on the inter-ventricular
septum below the annulus is primarily responsible for
conduction disturbances. In our study new LBBB, CHB,
and the need for PPM were associated with low implant
height, long PR interval, and longer QRS width. As such,
one could surmise that higher implantation in patients with
long PR intervals or long QRS durations might reduce the
necessity for PPM implantation and avoid conduction
Figure 1. Stent Compressing the Interventricular Septum
Coronal oblique maximum intensity projection from a cardiac computed
tomography examination of an 83-year-old male patient 3 days post-tran-
scatheter aortic valve replacement complicated by the development of
heart block. The inferior margin (arrow) of the balloon-expandable prosthe-
sis is 7.0 mm below the native annulus and seems to be compressing the
interventricular septum.
Table 4. Stent Geometry and Position in Patients Wi
Conduction
Disturbance
Prosthesis
Size (mm)
Inflow
Expansion (%)
LBBB 1 23 102.9
LBBB 2 26 93.8
LBBB 3 29 100.0
LBBB 4 29 97.6
CHB 1 26 111.7
CHB 2 26 97.4
CHB 3 26 109.8
CHB 4 26 100.6
The implant depth was significantly lower in patients who developed
mm vs. 5.5 2.9 mm, p 0.01).CHB complete heart block; LBBB left bundle branch block.delays. Of course, this has to be counterbalanced by the risk
for embolization or significant PAR related to “high” THV
implantation (14). This has to be especially considered
when implanting smaller-diameter THVs, which also have
a shorter landing zone due to decreased stent height.
Paravalvular regurgitation is associated with worse prog-
nosis after TAVR (15,16). We hypothesized that the
post-implant THV geometry defined by expansion and
eccentricity might explain PAR. However, neither expan-
sion nor eccentricity explained PAR. This contrasts with
a smaller study with 42 patients (7), which showed an
association between stent eccentricity and PAR. The
SAPIEN XT THV consistently became circular and fully
expanded, irrespective of the native annular anatomy. A
strong post-implant MDCT association with PAR was
the relation of the outer stent frame inflow area to the
native annular area (effective annular area oversizing).
This finding supports a prior study that showed a similar
relationship between THV area oversizing and PAR
burden and severity (7).
Although the THV stent diameter was generally smaller
than the MDCT native annulus long axis, this did not
translate to an unacceptable rate of PAR in this cohort.
However, patients with any degree of PAR had more
undersized valves measured by stent diameter in comparison
with the MDCT native annulus long axis. The explanation
nduction Disturbances
Inflow
ccentricity (%)
Annular Area
Oversizing (%)
Implant
Depth (mm)
3 Na 4.0
1.2 1.4 0.5
5.4 10.9 6.5
4.1 15.2 4.5
1.5 14 7
2.7 0.4 10
1.2 3.5 4
4.2 0.8 7.3
duction disturbances compared with patients who did not (3.4 2.0
Table 5. SAPIEN XT Post-Implant Valve Gradient and Effective Orifice
Areas According to Labeled Transcatheter Heart Valve Size
Labeled Prosthesis Size
Mean Gradient
(mm Hg)
Valve Area
(cm2)
20 mm 17.5 10.6 1.5 0.3
23 mm 11.6 4.4 1.5 0.3
26 mm 10.3 3.4 1.7 0.4
29 mm 7.3 2.4 2.3 0.5
The only predictor for the mean gradient or the effective orifice area was the labeled valve size
(p  0.001 and p  0.001, respectively). Stent expansion and eccentricity were not related to
hemodynamic performance measures.th Co
E
new con
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467might be that, as the oval native annulus becomes less
eccentric by placement of a rigid and consistently circular
THV stent, the native annulus short axis widens, and the
native annulus long axis shortens, thereby sealing the
paravalvular space. Oversizing measurements based on TEE
showed only a trend toward more PAR with less oversizing,
which is in accordance with previous reports (17), highlight-
ing limitations of 2-dimensional assessments of the complex
aortic annulus shape.
The finding of THV circularity and full expansion in
most of our patients also accounts for the lack of an
association between THV geometry and transvalvular gra-
dient or the effective THV orifice area. The only significant
predictor for valve area and gradient was the labeled THV
size. These data would suggest that, in patients with
borderline annular size, the selection of a larger prosthesis
might allow for reduction in both transvalvular gradients
and a lower likelihood of patient prosthesis mismatch.
However, the potential benefits of more extensive area
oversizing must be balanced with the potential risk of
annular injury (18).
Study limitations. Although this is the largest reported
cohort of post-implant MDCT evaluation of the geometry
and position of balloon-expandable THVs, the absolute
numbers for the measured outcomes are still relatively small
and warrant confirmation in larger trials. Because most
patients received 23- or 26-mm THV sizes, the results have
to be interpreted with caution with regard to the smaller
20-mm THV (n  2) and the larger 29-mm THV (n  7).
The PAR analysis was based on none versus any degree of
PAR, because more-than-mild PAR was rarely observed.
However, the clinical impact of mild PAR is subject to
ongoing debate. We chose, on the basis of an internal
MDCT sizing algorithm (19), the labeled valve size to
slightly oversize the native annulus area (annulus area
oversizing in this cohort 6.7  12.6%). We cannot
exclude that aggressive area oversizing (20%) could
have increased the rate of new LBBB or CHB, irrespec-
Table 6. Association of PAR With Different Oversizing Measurements
Oversizing Measurement
No PAR
(n  22)
Mild or More PAR
(n  67) p Value
TTE effective diameter oversizing 2.4 1.8 2.4 2.1 0.953
TEE effective diameter oversizing 2.3 1.0 1.7 1.4 0.067
MDCT effective short diameter
oversizing
3.7 1.8 3.5 1.8 0.730
MDCT effective long diameter
oversizing
0.7 2.3 1.9 1.9 0.026
MDCT effective area oversizing (%) 12.8 11.4 4.9 12.9 0.025
Values are millimeters, unless otherwise indicated.
MDCT  multidetector computed tomography; PAR  paravalvular regurgitation; TEE 
transesophageal echocardiography; TTE transthoracic echocardiography.tive of implant depth.Conclusions
A low implantation of balloon-expandable THVs is associ-
ated with clinically significant new conduction disturbances
and PPM implantation. Importantly, annular area oversiz-
ing was not associated with these complications. Future
studies might show whether purposeful higher implantation
can reduce conduction abnormalities without increasing
risk.
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